Elan A. Cohen, PhD

CenExel Hassman Research Institute, Marlton, New Jersey

  • 2Articles
  • 9.6KReads
  • 2022–2025Active
  • 19Collaborators
  • 14Citations

About

Elan A. Cohen, PhD, is affiliated with the CenExel Hassman Research Institute in Marlton, New Jersey. Cohen has published research on major depressive disorder, focusing on the efficacy, tolerability, and safety of novel TRPC4/5 inhibitors in patients with inadequate response to antidepressants. Additional work includes evaluation of digital medicine systems and their impact on inpatient psychiatric hospitalization rates for adults with schizophrenia. Cohen's contributions span clinical trials and psychiatric treatment innovations from 2022 to 2025.

Publications

JCP
BI 1358894 in Patients With Inadequate Antidepressant Response
JCP
Effects of a Digital Medicine System on Psychiatric Hospitalization Rates for Adults With Schizophrenia

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.